Scienture Holdings, Inc. (NasdaqCM: SCNX)
Health Care · Health Care Technology · US
$0.16
-42.75% today · -81.2% 1Y
Scienture Holdings, Inc. (NasdaqCM: SCNX) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $6.52M and employs 9 people.
Over the last twelve months the share price has lost 81.2%, trading between 0.13 and 2.60.
Tweenvest scores Scienture Holdings, Inc. across four factors: quality 57/100, value 65/100. Its strongest factor is value.
SCNX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.52M
- Revenue (TTM)
- $821.32K
- P/E
- —
- EPS
- -1.30
- Dividend yield
- —
- Beta (5Y)
- 4.08
- 52-week high
- $2.60
- 52-week low
- $0.13
- Avg volume (3M)
- —
- Shares outstanding
- 41.06M
- Employees
- 9
- Next earnings
- —
About Scienture Holdings, Inc.
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.
- ISIN
- US80880X1046
- Listed since
- Feb 6, 2014
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| TALi Digital LimitedASX: TD1 | $7.20M | AU$0.08 | -11.36% |
| Careteq LimitedASX: CTQ | $7.13M | AU$0.01 | -6.67% |
| Aclarion, Inc.NasdaqCM: ACON | $6.86M | $2.31 | -2.94% |
| HealthLynked Corp.OTCPK: HLYK | $6.83M | $2.30 | +16.81% |
| Media Lab S.p.A.ENXTPA: MLLAB | $6.37M | €2.40 | -3.23% |
| Adheris Health LimitedASX: AHE | $5.76M | AU$0.01 | +8.33% |
| eChannelling PLCCOSE: ECL.N0000 | $5.47M | SLRs14.80 | -5.73% |
| Pangenomic Health Inc.CNSX: NARA | $5.41M | CA$0.30 | +20.00% |
Figures last refreshed Oct 4, 2026.